OXIGENE, INC.
Patent Owner
Stats
- 1 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Sep 03, 2015 most recent publication
Details
- 1 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 146 Total Citation Count
- Oct 22, 1990 Earliest Filing
- 28 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
6746758 Insulating material and electric machine winding and method for manufacturing the sameAug 01, 02Jun 08, 04[H02K, B32B]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0141,349 Method and Composition for Alleviating Tumor SymptomsAbandonedJun 21, 13May 21, 15[A61K]
2012/0220,554 Combretastatins for Prevention of Posterior Capsule OpacificationAbandonedJan 02, 12Aug 30, 12[A61K, C07F, C07C, A61P]
2011/0110,940 Methods for Enhancing the Efficacy of Vascular Disrupting AgentsAbandonedApr 15, 09May 12, 11[A61K, A61P]
2009/0258,937 Methods for Modulating Tumor Growth and MetastasisAbandonedNov 07, 08Oct 15, 09[A61K, A61P]
2009/0209,496 METHODS AND COMPOSITIONS FOR ENHANCING THE EFFICACY OF RTK INHIBITORSAbandonedFeb 17, 09Aug 20, 09[A61K, A61P]
2009/0137,687 Compositions and Methods With Enhanced Therapeutic ActivityAbandonedJun 19, 08May 28, 09[A61K]
2009/0012,325 Methods for preparing phosphoric acids of combrestastatin and derivatives thereofAbandonedFeb 21, 08Jan 08, 09[C07F]
2008/0214,509 Methods for enhancing the efficacy of vascular disrupting agentsAbandonedMar 03, 08Sep 04, 08[A61K, A61P]
2006/0194,770 Methods for modulating tumor growth and metastasisAbandonedMay 01, 06Aug 31, 06[A61K, A01N]
2006/0135,625 Method of administering split doses of a vascular targeting agentAbandonedFeb 06, 06Jun 22, 06[A01N]
2006/0100,179 Compositions and methods for use in targeting vascular destructionAbandonedApr 22, 05May 11, 06[A61K, A01N]
2005/0245,489 Chromene-containing compounds with anti-tubulin and vascular targeting activityAbandonedMay 03, 04Nov 03, 05[A61K, C07D]
2004/0229,960 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseasesAbandonedDec 09, 03Nov 18, 04[A61K]
2004/0067,255 Method of administering split doses of a vascular targeting agentAbandonedOct 07, 02Apr 08, 04[A61K]
6713517 Use of aryl N-substituted carboxamides directly and as radio-and chemosensitizers for killing tumor and cancer cells and novel compounds for such useExpiredFeb 27, 97Mar 30, 04[A01N]
2003/0181,531 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseasesAbandonedFeb 11, 03Sep 25, 03[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.